Clinical Trial Update: Verapamil and Catamenial Epilepsy [NA]

View source ↗

Summary

The clinical trial evaluating verapamil for catamenial epilepsy has been withdrawn. The status is Withdrawn with no further details provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catamenial Epilepsy

Drugs mentioned

• Verapamil (verapamil)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Catamenial Epilepsy | NA | Status: WITHDRAWN